# A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

> **NCT07081958** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Hoffmann-La Roche** · enrollment: 352 (actual)

## Conditions studied

- Obesity or Overweight

## Interventions

- **DRUG:** RO7795081
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07081958
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-29
- **Primary completion:** 2026-04-28
- **Final completion:** 2026-07-17
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07081958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07081958, "A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT07081958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*